This review aimed to highlight the main areas of focus in the research field surrounding CD133 as well as gaps in defined relationships regarding biologic signaling prediction and prognosis, the tumor microenvironment, resistance, and recurrence. The gene discussed is PROM1; the disease is neoplasm.